Cepheid
Total Raised
$60.7MInvestors Count
13Deal Terms
3Funding, Valuation & Revenue
8 Fundings
Cepheid has raised $60.7M over 8 rounds.
Cepheid's latest funding round was a Grant for $28M on July 30, 2021.
Cepheid's valuation in November 2016 was $4,000M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/30/2021 | Grant | $28M | U.S. Department of Health and Human Services | 1 | ||
11/5/2016 | Acq - P2P | $4,000M | ||||
6/21/2000 | IPO | |||||
1/6/2000 | Series C | |||||
10/1/1998 | Series A |
Date | 7/30/2021 | 11/5/2016 | 6/21/2000 | 1/6/2000 | 10/1/1998 |
|---|---|---|---|---|---|
Round | Grant | Acq - P2P | IPO | Series C | Series A |
Amount | $28M | ||||
Investors | U.S. Department of Health and Human Services | ||||
Valuation | $4,000M | ||||
Revenue | |||||
Sources | 1 |
Cepheid Deal Terms
3 Deal Terms
Cepheid's deal structure is available for 3 funding rounds, including their Acq - P2P from November 05, 2016.
Round | Acq - P2P | Series A | Series B |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - P2P | |||||||||||||||
Series A | |||||||||||||||
Series B |
Cepheid Investors
13 Investors
Cepheid has 13 investors. U.S. Department of Health and Human Services invested in Cepheid's Grant funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/30/2021 | 7/30/2021 | U.S. Department of Health and Human Services | 1 Grant | Government | DC | |
11/5/2016 | 11/5/2016 | 1 Acq - P2P | Corporation | DC | ||
4/13/1998 | 1/6/2000 | 2 Series B, Series C (2000) | Corporation | Minnesota | ||
Investment Bank | New York | |||||
Corporation | Belgium |
First funding | 7/30/2021 | 11/5/2016 | 4/13/1998 | ||
|---|---|---|---|---|---|
Last Funding | 7/30/2021 | 11/5/2016 | 1/6/2000 | ||
Investor | U.S. Department of Health and Human Services | ||||
Rounds | 1 Grant | 1 Acq - P2P | 2 Series B, Series C (2000) | ||
Board Seats | |||||
Type | Government | Corporation | Corporation | Investment Bank | Corporation |
Location | DC | DC | Minnesota | New York | Belgium |
Cepheid Acquisitions
2 Acquisitions
Cepheid acquired 2 companies. Their latest acquisition was OncoMark on December 16, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/16/2021 | Other | $9.9M | Acquired | 4 | ||
10/3/2014 |
Date | 12/16/2021 | 10/3/2014 |
|---|---|---|
Investment Stage | Other | |
Companies | ||
Valuation | ||
Total Funding | $9.9M | |
Note | Acquired | |
Sources | 4 |
Compare Cepheid to Competitors
Cambridge Medical Technologies designs and manufactures medical devices within the healthcare sector. Its offerings include nanoscale fluid sampling and testing systems that access subcutaneous interstitial fluid to detect blood analytes. These devices are used for monitoring blood chemistry and providing patient biomarker data to support medical specialties. It was founded in 2016 and is based in Cambridge, United Kingdom.
PerkinElmer operates as a provider of technology and service solutions in the laboratory sector, focusing on food, industrial, life sciences, and environmental markets. The company offers a range of products and services, including laboratory technologies for analysis and characterization, atomic spectroscopy, chromatography, and food quality analyzers. PerkinElmer's solutions help customers evaluate the quality and safety of products. It was founded in 1937 and is based in Shelton, Connecticut.
Gore manufactures medical devices within the healthcare sector. The company offers medical devices that use fluoropolymer technology to address various medical problems, including aortic, cardiac, peripheral, and surgical needs. Gore serves healthcare professionals and institutions that require medical technologies to support patient care. It was founded in 1958 and is based in Newark, Delaware.
Vitalchat provides artificial intelligence (AI)-powered ambient virtual care solutions. Its main offerings include a platform for continuous remote patient monitoring, electronic health record (EHR) integration, and AI-assisted risk detection. The company serves the healthcare industry and addresses challenges such as nursing shortages and care coordination. It was founded in 2021 and is based in Raleigh, North Carolina.
Biomeme focuses on DNA diagnostics and disease surveillance in healthcare and research. The company provides a platform that allows smartphones to analyze and identify pathogens and diseases based on their DNA or RNA signatures. Biomeme serves the healthcare, agriculture, environmental, veterinary, and educational sectors with mobile testing solutions. It was founded in 2012 and is based in Philadelphia, Pennsylvania.
Meterbolic conducts metabolic health assessments and preventive healthcare within the medical diagnostics sector. The company offers tests that measure insulin response and other metabolic markers to predict the risk of diabetes and other chronic diseases, which can assist in health management. Meterbolic serves individuals seeking health monitoring and those interested in preventive healthcare. It was founded in 2018 and is based in London, United Kingdom.
Loading...